Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Philips bolstered by outlook for healthcare business

Published 01/26/2016, 05:18 AM
Updated 01/26/2016, 05:30 AM
© Reuters. A Philips logo is seen at Philips headquarters in Amsterdam

By Toby Sterling

AMSTERDAM (Reuters) - Strong orders for its healthcare business helped to boost shares in Philips (AS:PHG), the Dutch company which is seeking to focus on scanners and medical technology and shed its traditional lighting operations.

Philips CEO Frans van Houten said he expected modest growth in sales and earnings in 2016, with improvements mostly coming in the second half of the year.

The company saw an increase in sales in China, its biggest growth market, although Van Houten could not say whether he expected the trend to continue as the economy there slows.

"It's certainly gratifying to see the rebound, both in orders and sales growth, especially on the healthcare side, but it comes after several quarters of slow growth," van Houten told reporters.

"I don't think we can declare that the (China) slowdown is over after one quarter."

Van Houten said the company remained on course to sell or float its lighting division in the first half of this year.

Last week the U.S. blocked Philips' plan to sell an 80 percent stake in its Lumileds lighting components division to Chinese investors for $2.7 billion.

Van Houten said that division will now likely be sold for a lesser amount in the second half of 2016.

The breakdown of the Lumileds deal left Philips under pressure as it tries to carry out several strategic operations at once.

It has been attempting to spin off its lighting and lighting components businesses since 2014 to focus on its core businesses of medical scanners and healthcare technology.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Shares, which were down 18 percent over the past 12 months, initially surged 8 percent in Amsterdam and traded 4.7 percent higher at 0955 GMT.

Results "were as good as we've seen in a long time," Barclays (L:BARC) analysts said in a note.

"Comparable intake in Healthcare reached 15 percent, by far the highest of the big three," they said, referring to Philips and its main competitors GE (N:GE), and Siemens (DE:SIEGn).

Barclays has a 'neutral' rating on Philips shares.

Shares in Siemens also rose 6.6 percent on Tuesday after the German company raised its full-year earnings forecast on the back of a strong start to its financial year.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.